By Shashwat Chauhan (Reuters) – Short sellers of artificial intelligence-related stocks raked in bumper profits after the...
By Will Dunham WASHINGTON (Reuters) – Atomic scientists on Tuesday moved their “Doomsday Clock” closer to midnight...
(Reuters) -Novo Nordisk said on Tuesday the U.S. FDA has approved its blockbuster drug Ozempic to lower...
(Reuters) – Microsoft-backed artificial intelligence (AI) bellwether OpenAI has launched ChatGPT Gov, a tailored version of ChatGPT...
By Davide Barbuscia NEW YORK (Reuters) – Wall Street is asking regulators for more time to implement...
By Prakhar Srivastava and Pritam Biswas (Reuters) -Metsera, which is developing weight-loss drugs, said on Monday it...
By Stephen Nellis SAN FRANCISCO (Reuters) -Nvidia on Monday said Chinese AI firm DeepSeek’s advances show the...
WASHINGTON (Reuters) -The Justice Department is firing more than a dozen officials who worked on Special Counsel...
(Reuters) – Amazon’s Prime Video has shifted its strategic focus towards live sports and away from original...
(Reuters) – Wall Street banks are preparing to sell a big portion of debt holdings in social...
